Central Line Associated Blood Stream Infections in Pediatric Hematology/Oncology Patients With Different Types of Central Lines

Pediatric Blood and Cancer

Volumn 63, Issue 9, 2016, Pages 1603-1607

  Hord, Jeffrey D ^a   Lawlor, John ^b   Werner, Eric ^c   Billett, Amy L ^d   Bundy, David G ^e   Winkle, Cindi ^f   Gaur, Aditya H ^g  

^a AKRON CHILDREN'S HOSPITAL   (United States)

^b Children's Hospital Association   (United States)

^c Children's Hospital of the King's Daughters   (United States)

^d DANA FARBER CANCER INSTITUTE   (United States)

^e MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^f CHILDREN S MEDICAL CENTER   (United States)

^g ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

central lines; CLABSI; infections, infections in immunocompromised hosts, pediatric hematology oncology

Indexed keywords

ACUTE LYMPHOBLASTIC LEUKEMIA; ACUTE MYELOBLASTIC LEUKEMIA; ARTICLE; CANCER PATIENT; CATHETER INFECTION; CENTRAL NERVOUS SYSTEM TUMOR; CENTRAL VENOUS CATHETER; CHILD; CLINICAL ARTICLE; FEMALE; FUNGUS; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HOSPITAL PATIENT; HUMAN; MALE; NONHUMAN; PERIPHERALLY INSERTED CENTRAL VENOUS CATHETER; PRIORITY JOURNAL; SOLID TUMOR; TOTALLY IMPLANTED CATHETER; TUNNELED EXTERNALIZED CATHETER;

EID: 84978745436     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.26053     Document Type: Article

References (18)

1. Simon A, Ammann RA, Bode U, Fleischhack G, Wenchel HM, Schwamborn D, Gravou C, Schlegel PG, Rutkowski S, Dannenberg C, Korholz D, Laws HJ, Kramer MH. Healthcare-associated infections in pediatric cancer patients: Results of a prospective surveillance study from university hospitals in Germany and Switzerland. BMC Infect Dis 2008 May 23;8:70.
2. McLean TW, Fisher CJ, Snively BM, Chauvenet AR. Central venous lines in children with lesser risk acute lymphoblastic leukemia: Optimal type and timing of placement. J Clin Oncol 2005;23:3024–3029.
3. Adler A, Yaniv I, Steinberg R, Solter E, Samra Z, Stein J, Levy I. Infectious complications of implantable ports and Hickman catheters in pediatric hematology-oncology patients. J Hosp Infection 2006;62:358–365.
4. Allen RC, Holdsworth MT, Johnson CA, Chavez CM, Heideman RL, Overturf G, Lemon D, Hunt WC, Winter SS. Risk determinants for catheter-associated blood stream infections in children and young adults with cancer. Pediatr Blood Cancer 2008;51:53–58.
5. Kelly MS, Conway M, Wirth KE, Potter-Bynoe G, Billett AL, Sandora TJ. Microbiology and risk factors for central line-associated bloodstream infections among pediatric oncology outpatients: A single institution experience of 41 cases. J Pediatr Hematol Oncol 2013;35:e71–e76.
6. Ammann RA, Laws HJ, Schrey D, Ehlert K, Moser O, Dilloo D, Bode U, Wawer A, Schrauder A, Cario G, Laengler A, Graf N, Furtwangler R, Simon A. Bloodstream infection in paediatric cancer centres–leukaemia and relapsed malignancies are independent risk factors. Eur J Pediatr 2015; 174:675–686.
7. Orgel E, Ji L, Pastor W, Schore RJ. Infectious morbidity by catheter type in neutropenic children with cancer. Pediatr Infect Dis J 2013;33:263–266.
8. Bundy DG, Gaur, AH, Billett AL, He, B, Colantuoni EA, Miller MR. Preventing CLABSIs among pediatric hematology/oncology inpatients: National collaborative results. Pediatrics 2014;134: e1678–e1685.
9. Centers for Disease Control and Prevention's (CDC). National Healthcare Safety Network (NHSN) device associated module. http://www.cdc.gov/nhsn/PDFs/pscManual/4PSC_CLABScurrent.pdf. Updated January 2015, Accessed March 3, 2015.
10. Dudeck MA, Weiner LM, Allen-Bridson K, Malpiedi PJ, Peterson KD, Pollock DA, Sievert DM, Edwards JR. National Healthcare Safety Network (NHSN) report, data summary for 2012, device-associated module. Am J Infect Control 2013;41:1148–1166.
11. Bratton J, Johnstone PA, Mcmullen KP. Outpatient management of vascular access devices in children receiving radiotherapy: Complications and morbidity. Pediatr Blood Cancer 2014;61:499–501.
12. Rinke ML, Milstone AM, Chen AR, Mirski K, Bundy DG, Colantuoni E, Pehar M, Herpst C, Miller MR. Ambulatory pediatric oncology CLABSIs: Epidemiology and risk factors. Pediatr Blood Cancer 2013;60:1882–1889.
13. Kelly MJ, Vivier PM, Panken TM, Schwartz CL. Bacteremia in febrile nonneutropenic pediatric oncology patients. Pediatr Blood Cancer 2010;54:83–87.
14. Smith TL, Pullen GT, Crouse V, Rosenberg J, Jarvis WR. Bloodstream infections in pediatric oncology outpatients: A new healthcare systems challenge. Infect Control Hosp Epidemiol 2002;23:239–243.
15. Flynn PM, Willis B, Gaur AH, Shenep JL. Catheter design influences recurrence of catheter-related bloodstream infection in children with cancer. J Clin Oncol 2003;21:3250–3255.
16. Chopra V, O'Horo JC, Rogers MA, Maki DG, Safdar N. The risk of bloodstream infection associated with peripherally inserted central catheters compared with central venous catheters in adults: A systematic review and meta-analysis. Infect Control Hosp Epidemiol 2013;34:908–918.
17. Rinke ML, Bundy DG, Chen AR, Milstone AM, Colantuoni E, Pehar M, Herpst C, Fratino L, Miller MR. Central line maintenance bundles and CLABSIs in ambulatory oncology patients. Pediatrics 2013;132:e1403–e1412.
18. Valentino LA, Ewenstein B, Navickis RJ, Wilkes MM.Central venous access devices in haemophilia. Haemophilia 2004; 10:134–146.